Page last updated: 2024-08-24

meglumine antimoniate and Dizziness

meglumine antimoniate has been researched along with Dizziness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araujo-Melo, MH; Araújo-Silva, M; Carmo, CN; Conceição-Silva, F; Meneses, AM; Moreira, JS; Oliveira, RV; Pimentel, MI; Salgueiro, MM; Schubach, AO; Valete-Rosalino, CM1

Other Studies

1 other study(ies) available for meglumine antimoniate and Dizziness

ArticleYear
Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil.
    The Journal of laryngology and otology, 2010, Volume: 124, Issue:10

    Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Mucocutaneous; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Odds Ratio; Organometallic Compounds; Retrospective Studies; Risk Factors; Sex Distribution; Young Adult

2010